Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of L-Theanine in Boys With ADHD

This study has been completed.
Sponsor:
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00291070
First received: February 9, 2006
Last updated: April 28, 2008
Last verified: April 2008

February 9, 2006
April 28, 2008
October 2005
July 2006   (final data collection date for primary outcome measure)
Cognitive performance [ Time Frame: Unspecified ] [ Designated as safety issue: No ]
Cognitive performance
Complete list of historical versions of study NCT00291070 on ClinicalTrials.gov Archive Site
Sleep quality, hyperactive behaviors, anxiety [ Time Frame: Unspecified ] [ Designated as safety issue: No ]
Sleep quality, hyperactive behaviors, anxiety
Not Provided
Not Provided
 
Effects of L-Theanine in Boys With ADHD
A Double Blind, Randomized Placebo Controlled Clinical Trial Examining the Effects of L-Theanine (Suntheanine®) in Male Child Subjects With Attention Deficit Hyperactivity Disorder

This study will examine the effects of L-theanine (an amino acid found in green tea) on the behavior, cognitive performance and sleep quality of boys with ADHD.

Not Provided
Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Attention Deficit Hyperactivity Disorder
Drug: L-theanine
This study will examine the effects of L-theanine (an amino acid found in green tea) on the behavior, cognitive performance and sleep quality of boys with ADHD.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
July 2006
July 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

Diagnosis of attention deficit hyperactivity disorder (ADHD)

Exclusion Criteria:

-

Male
8 Years to 12 Years
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00291070
C04-0605
Not Provided
Dr. Michael Lyon, University of British Columbia
University of British Columbia
Not Provided
Principal Investigator: Dr. Michael Lyon University of British Columbia
University of British Columbia
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP